Przemysław Nowacki Selected Research

Przemysław Nowacki Research Topics

Disease

16	Stroke (Strokes) 01/2021 - 05/2003
12	Ischemic Stroke 01/2020 - 05/2004
4	Atrial Fibrillation 09/2019 - 03/2012
3	Neoplasms (Cancer) 01/2021 - 01/2003
3	Glioma (Gliomas) 01/2021 - 01/2003
3	Inflammation (Inflammations) 01/2020 - 01/2010
3	Atherosclerotic Plaque (Atheroma) 01/2017 - 05/2004
3	Atherosclerosis 01/2015 - 03/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2003
2	Liver Diseases (Liver Disease) 12/2013 - 07/2013
1	Dementia (Dementias) 01/2021
1	Cognitive Dysfunction 01/2021
1	Multiple Sclerosis 04/2020
1	Neuroinflammatory Diseases 02/2020
1	Cysts 01/2020
1	Cushing Syndrome 01/2020
1	Central Nervous System Cysts (Suprasellar Cyst) 01/2020
1	Adenoma (Adenomas) 01/2020
1	Hyperplasia 01/2020
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2020
1	Embolic Stroke 03/2019
1	Disease Progression 04/2018
1	Coronary Disease (Coronary Heart Disease) 05/2016
1	Hypoglycemia (Reactive Hypoglycemia) 10/2015
1	Brain Ischemia (Cerebral Ischemia) 10/2015
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2015
1	Speech Disorders (Cluttering) 01/2015
1	Hemorrhagic Stroke 01/2015
1	Cerebral Hemorrhage 01/2015
1	Articulation Disorders (Speech Articulation Disorder) 01/2015
1	Hypertension (High Blood Pressure) 01/2014
1	Dyslipidemias (Dyslipidemia) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2013
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2013
1	Hepatic Encephalopathy 12/2013
1	Thrombosis (Thrombus) 07/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2011
1	Temporal Lobe Epilepsy 01/2011
1	Infections 01/2011
1	Lacunar Stroke 03/2010
1	Central Nervous System Diseases (CNS Diseases) 11/2009
1	Melanoma (Melanoma, Malignant) 01/2007
1	Hydrocephalus (Hydrocephaly) 01/2007
1	Headache (Headaches) 01/2007
1	Seizures (Absence Seizure) 01/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2007
1	Lung Neoplasms (Lung Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2007
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2019 - 03/2012
3	C-Reactive ProteinIBA 04/2014 - 01/2010
2	Methionine (L-Methionine)FDA Link 01/2020 - 05/2017
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 01/2018
2	AnticoagulantsIBA 09/2019 - 05/2003
2	LipidsIBA 05/2016 - 01/2014
2	AntibodiesIBA 01/2014 - 01/2011
2	Fibrinogen (Factor I)FDA Link 07/2011 - 01/2010
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2010 - 01/2007
1	stearidonic acidIBA 01/2021
1	tricosanoic acidIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Arachidonic Acid (Vitamin F)IBA 01/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 02/2020
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 04/2018
1	Valine (L-Valine)FDA Link 05/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2017
1	Chemokine CX3CL1IBA 01/2017
1	GlycogenIBA 10/2015
1	Neuroprotective AgentsIBA 10/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2015
1	Levodopa (L Dopa)FDA LinkGeneric 01/2015
1	HDL CholesterolIBA 01/2015
1	oxidized low density lipoproteinIBA 01/2014
1	Anti-Idiotypic AntibodiesIBA 01/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2013
1	CytokinesIBA 12/2013
1	InterleukinsIBA 12/2013
1	milk-derived factorIBA 07/2013
1	Oxidoreductases (Dehydrogenase)IBA 03/2012
1	S100 Proteins (S 100 Protein)IBA 07/2011
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 07/2011
1	Fibrinolysin FDA Link 07/2011
1	AntigensIBA 01/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010

Therapy/Procedure

6	Therapeutics 04/2020 - 11/2009
2	Secondary Prevention 05/2016 - 03/2012
1	Transplantation 04/2018
1	Stroke Rehabilitation 05/2017
1	Transcranial Magnetic Stimulation 05/2017
1	Glycemic Control 01/2007
1	Thrombolytic Therapy 01/2007
1	Activities of Daily Living (ADL) 01/2006
1	Neurosurgical Procedures 01/2006